Skip to main content

TableĀ 2 Clinical presentations of patients with tuberculous meningitis and Brucella meningitis

From: Chronic meningitis in adults: a comparison between neurotuberculosis and neurobrucellosis

Ā 

TBM (nā€‰=ā€‰28)

BM (nā€‰=ā€‰42)

Risk ratio (95% CI)

P-value

Headache, n (%)

15/21 (71.4)

37/40 (92.5)

0.77 (0.58 to 1.03)

0.052

Nausea/Vomiting, n (%)

11/20 (55.0)

26/35 (74.3)

0.74 (0.48 to 1.15)

0.143

Fever, n (%)

19/21 (90.5)

29/38 (76.3)

1.19 (0.95 to 1.49)

0.297

Altered consciousnessa, n (%)

19/27 (70.4)

14/41 (34.2)

2.06 (1.26 to 3.37)

0.003

Seizures, n (%)

4/26 (15.4)

6/40 (15.0)

1.03 (0.32 to 3.29)

1.000

Neck stiffness, n (%)

5/19 (26.3)

13/30 (43.3)

0.61 (0.26 to 1.43)

0.229

Neurologic deficits, n (%)

9/20 (45.0)

8/36 (22.2)

2.03 (0.93 to 4.42)

0.076

Extra-neural involvement, n (%)

16 (57.1)

5 (11.9)

4.80 (1.98 to 11.61)

ā€‰<ā€‰0.001

  1. TBM Tuberculous meningitis, BM Brucella meningitis, 95% CI 95% confidence interval
  2. aDefined as Glasgow coma scale (GCS) ofā€‰<ā€‰15